To provide long term data from clinical practices in treatment of Myocardial Infarction patients with stable coronary artery disease.
- Registration Number
- CTRI/2013/08/003931
- Lead Sponsor
- AstraZeneca AB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
The subject population that will be observed in the NIS must fulfil all of the following criteria:
1.
Provision of subject informed consent
2.
Female and/or male aged 50 years and over
3.
Documented history of presumed spontaneous MI (excluding known peri-procedural or definite secondary MI [eg, due to profound hypotension, hypertensive emergency, tachycardia, or profound anemia]) with their most recent MI occurring 1 to 3 years prior to enrollment and have at least 1 of the following risk factors:
Age . 65 years
. Diabetes mellitus requiring medication
. Documented history of a second prior presumed spontaneous MI ( >1 year ago)
. Documented history of angiographic evidence of multivessel coronary artery disease (CAD)
. Chronic, non-end stage renal dysfunction (15 mL/min . creatinine clearance, calculated by Cockcroft Gault equation, <60 mL/min)
Patients will not be eligible to participate if any of the following exclusion criteria are present:
1.
Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language where interpreter services are not reliably available, psychiatric disturbances, alcohol or drug abuse).
2.
Presence of serious/severe co-morbidities in the opinion of the investigator which may limit life expectancy ( <1 year).
3.
Current participation in a blinded randomized clinical trial.
4.
Patients receiving treatment of ticagrelor beyond 12 months or off label use of ticagrelor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method